Vidya Gopalakrishnan

2.7k total citations
81 papers, 1.9k citations indexed

About

Vidya Gopalakrishnan is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Vidya Gopalakrishnan has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 16 papers in Genetics and 12 papers in Oncology. Recurrent topics in Vidya Gopalakrishnan's work include Epigenetics and DNA Methylation (19 papers), Glioma Diagnosis and Treatment (14 papers) and DNA Repair Mechanisms (11 papers). Vidya Gopalakrishnan is often cited by papers focused on Epigenetics and DNA Methylation (19 papers), Glioma Diagnosis and Treatment (14 papers) and DNA Repair Mechanisms (11 papers). Vidya Gopalakrishnan collaborates with scholars based in United States, India and Italy. Vidya Gopalakrishnan's co-authors include Sathees C. Raghavan, Bibha Choudhary, Charles G. Eberhart, Pete Taylor, Johannes Wolff, Chandra Das, Subhas S. Karki, Sujeet Kumar, S A Khan and Gregory N. Fuller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Vidya Gopalakrishnan

78 papers receiving 1.9k citations

Peers

Countries citing papers authored by Vidya Gopalakrishnan

Since Specialization

Citations

This map shows the geographic impact of Vidya Gopalakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vidya Gopalakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vidya Gopalakrishnan more than expected).

Fields of papers citing papers by Vidya Gopalakrishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vidya Gopalakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vidya Gopalakrishnan. The network helps show where Vidya Gopalakrishnan may publish in the future.

Co-authorship network of co-authors of Vidya Gopalakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Vidya Gopalakrishnan. A scholar is included among the top collaborators of Vidya Gopalakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vidya Gopalakrishnan. Vidya Gopalakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Formation of multiple G-quadruplexes contributes toward BCR fragility associated with chronic myelogenous leukemia 2025 ·Nucleic Acids Research ·Shivangi Sharma, Elizabeth Thomas, Sumedha Dahal, Sayak Das, Shyam S. Kothari, (unknown), (unknown), Vidya Gopalakrishnan, Sathees C. Raghavan	2
2	REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma 2024 ·Scientific Reports ·(unknown), Donghang Cheng, Jyothishmathi Swaminathan, Yanwen Yang, Zheng Yan, Nancy Gordon, Vidya Gopalakrishnan	2
3	Mapping the Single-Cell Differentiation Landscape of Osteosarcoma 2024 ·Clinical Cancer Research ·Danh D. Truong, (unknown), (unknown), (unknown), (unknown), Jes Chauviere Lee, (unknown), (unknown), Najat C. Daw, Nancy Gordon, Vidya Gopalakrishnan, Richard Görlick, Neeta Somaiah, Joseph O. Deasy, Antonios G. Mikos, Allen Tannenbaum, Joseph A. Ludwig	10
4	Splicing is an alternate oncogenic pathway activation mechanism in glioma 2022 ·Nature Communications ·Robert Siddaway, (unknown), (unknown), (unknown), Jyothishmathi Swaminathan, Scott Ryall, Sanja Pajovic, Palak Patel, Javad Nazarian, Oren J. Becher, Michael Brudno, Arun Ramani, Vidya Gopalakrishnan, Cynthia Hawkins	26
5	G4 DNA present at human telomeric DNA contributes toward reduced sensitivity to γ-radiation induced oxidative damage, but not bulky adduct formation 2021 ·International Journal of Radiation Biology ·(unknown), Shivangi Sharma, (unknown), (unknown), Vidya Gopalakrishnan, Supriya V. Vartak, (unknown), Umesh Varshney, Sathees C. Raghavan	5
6	ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models 2020 ·Molecules ·(unknown), (unknown), (unknown), Sujeet Kumar, Kothanahally S. Sharath Kumar, Vidya Gopalakrishnan, Subhas S. Karki, Bibha Choudhary	36
7	Licochalcone A is a natural selective inhibitor of arginine methyltransferase 6 2020 ·Biochemical Journal ·Shuai Gong, Shinji Maegawa, Yanwen Yang, Vidya Gopalakrishnan, Guangrong Zheng, Donghang Cheng	14
8	Medulloblastoma epigenetics and the path to clinical innovation 2020 ·Journal of Neuro-Oncology ·Amanda R. Haltom, (unknown), Donghang Cheng, Shinji Maegawa, Vidya Gopalakrishnan, Soumen Khatua	8
9	Acute toxicity analysis of Disarib, an inhibitor of BCL2 2020 ·Scientific Reports ·Shivangi Sharma, Kontham Kulangara Varsha, (unknown), Vidya Gopalakrishnan, (unknown), Bibha Choudhary, Kempegowda Mantelingu, Sathees C. Raghavan	10
10	EpiSAFARI: sensitive detection of valleys in epigenetic signals for enhancing annotations of functional elements 2019 ·Bioinformatics ·Arif Harmanci, Akdes Serin Harmancı, Jyothishmathi Swaminathan, Vidya Gopalakrishnan	1
11	Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines 2019 ·BMC Complementary and Alternative Medicine ·(unknown), (unknown), (unknown), Vidya Gopalakrishnan, (unknown), Sujeet Kumar, Subhas S. Karki, Bibha Choudhary	44
12	MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes 2018 ·Molecular Cell ·Shilpa S. Dhar, Dongyu Zhao, Tao Lin, Bingnan Gu, (unknown), Sarah J. Wu, Hunain Alam, Jie Lv, Kyuson Yun, Vidya Gopalakrishnan, Elsa R. Flores, Paul A. Northcott, Veena Rajaram, Wei Li, Ali Shilatifard, Roy V. Sillitoe, Kaifu Chen, Min Gyu Lee	107
13	Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation 2017 ·Molecular Cancer Research ·(unknown), (unknown), Jyothishmathi Swaminathan, Chandra Das, Shavali Shaik, Rong-Hua Tao, Ciro Milite, Sabrina Castellano, Pete Taylor, Gianluca Sbardella, Vidya Gopalakrishnan	27
14	Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial 2015 ·Journal of Neuro-Oncology ·David I. Sandberg, Michael Rytting, Wafik Zaky, Marcia Kerr, Leena Ketonen, Uma Kundu, Bartlett D. Moore, Grace Meijuan Yang, Ping Hou, Clark Sitton, Laurence J.N. Cooper, Vidya Gopalakrishnan, Dean A. Lee, Peter F. Thall, Soumen Khatua	19
15	2-(4-Chlorobenzyl)-6-arylimidazo[2,1-b][1,3,4]thiadiazoles: Synthesis, cytotoxic activity and mechanism of action 2014 ·European Journal of Medicinal Chemistry ·Sujeet Kumar, Mahesh Hegde, Vidya Gopalakrishnan, (unknown), (unknown), Erik De Clercq, Dominique Schols, (unknown), Sathees C. Raghavan, Subhas S. Karki	29
16	REST Is a Novel Prognostic Factor and Therapeutic Target for Medulloblastoma 2012 ·Molecular Cancer Therapeutics ·Pete Taylor, Jason Fangusaro, Veena Rajaram, Stewart Goldman, Irene Helenowski, Tobey J. MacDonald, Martin Hasselblatt, Lars Riedemann, Álvaro Macedo Laureano, Laurence J.N. Cooper, Vidya Gopalakrishnan	40
17	The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferation 2012 ·Oncogene ·Chandra Das, Pete Taylor, Monica Gireud, A. L. Singh, Dean A. Lee, Gregory N. Fuller, Lingyun Ji, Jason Fangusaro, Veena Rajaram, Stewart Goldman, Charles G. Eberhart, Vidya Gopalakrishnan	35
18	Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF^β‐TRCP in neuroblastoma cells 2011 ·Cancer ·A. L. Singh, (unknown), Monica Gireud, Stephen A. Fletcher, James E. Baumgartner, Gregory N. Fuller, John Stewart, Peter E. Zage, Vidya Gopalakrishnan	47
19	The Notch Target Hes1 Directly Modulates Gli1 Expression and Hedgehog Signaling: A Potential Mechanism of Therapeutic Resistance 2010 ·Clinical Cancer Research ·Karisa C. Schreck, Pete Taylor, Luigi Marchionni, Vidya Gopalakrishnan, Eli E. Bar, Nicholas Gaiano, Charles G. Eberhart	143
20	DNA Replication Specificity and Functional E2 Interaction of the E1 Proteins of Human Papillomavirus Types 1a and 18 Are Determined by Their Carboxyl-Terminal Halves 1999 ·Virology ·Vidya Gopalakrishnan, (unknown), Saleem A. Khan	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact